GREGORI, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 6.290
AS - Asia 3.023
EU - Europa 2.875
SA - Sud America 445
AF - Africa 83
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.732
Nazione #
US - Stati Uniti d'America 6.084
SG - Singapore 1.004
CN - Cina 776
DE - Germania 496
IT - Italia 461
HK - Hong Kong 358
RU - Federazione Russa 352
SE - Svezia 321
BR - Brasile 318
VN - Vietnam 305
IE - Irlanda 255
GB - Regno Unito 204
UA - Ucraina 188
CA - Canada 174
IN - India 158
FR - Francia 149
PL - Polonia 94
FI - Finlandia 86
AT - Austria 65
BD - Bangladesh 55
DK - Danimarca 50
TR - Turchia 50
KR - Corea 43
AR - Argentina 41
ZA - Sudafrica 40
IQ - Iraq 38
IR - Iran 37
JP - Giappone 33
NL - Olanda 33
BE - Belgio 30
ID - Indonesia 23
ES - Italia 22
VE - Venezuela 21
MX - Messico 19
PK - Pakistan 17
EC - Ecuador 16
SA - Arabia Saudita 15
UZ - Uzbekistan 13
CO - Colombia 12
MY - Malesia 11
PH - Filippine 11
PY - Paraguay 10
CL - Cile 9
CZ - Repubblica Ceca 9
JO - Giordania 9
PT - Portogallo 9
RO - Romania 9
AE - Emirati Arabi Uniti 8
IL - Israele 8
UY - Uruguay 8
GR - Grecia 7
MA - Marocco 7
NP - Nepal 7
TW - Taiwan 7
AU - Australia 6
DZ - Algeria 6
EG - Egitto 6
ET - Etiopia 6
KE - Kenya 6
OM - Oman 6
AZ - Azerbaigian 5
BO - Bolivia 5
CH - Svizzera 5
EU - Europa 5
HU - Ungheria 5
LT - Lituania 5
TH - Thailandia 5
AL - Albania 4
BG - Bulgaria 4
PE - Perù 4
DO - Repubblica Dominicana 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
MD - Moldavia 3
MO - Macao, regione amministrativa speciale della Cina 3
NZ - Nuova Zelanda 3
TN - Tunisia 3
AM - Armenia 2
BH - Bahrain 2
GE - Georgia 2
LV - Lettonia 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LY - Libia 1
Totale 12.721
Città #
Ann Arbor 942
Singapore 606
Ashburn 577
Woodbridge 557
Chandler 339
San Jose 336
Hong Kong 333
Fairfield 328
Frankfurt am Main 279
Wilmington 258
Houston 250
Dublin 247
Jacksonville 208
Milan 202
Dearborn 194
Beijing 140
Seattle 136
New York 124
Cambridge 121
Santa Clara 112
Los Angeles 92
Princeton 82
Dallas 80
Ho Chi Minh City 79
Kraków 69
Hanoi 68
Shanghai 68
Nanjing 67
Chicago 62
Vienna 59
The Dalles 57
Ottawa 48
Wayne 43
Lachine 39
Lauterbourg 39
Hefei 38
São Paulo 38
Toronto 38
Helsinki 34
Moscow 34
Altamura 33
Buffalo 31
Council Bluffs 31
Guangzhou 30
Lawrence 30
Dong Ket 29
Brussels 28
Nanchang 28
Orem 28
Seoul 27
San Diego 26
Munich 22
Tokyo 22
Tianjin 19
Chennai 18
Fremont 18
Boardman 17
Brooklyn 17
Changsha 17
Hangzhou 17
Johannesburg 17
London 17
Baghdad 15
Jakarta 15
Shenyang 15
Warsaw 15
Pune 14
Montreal 13
Mumbai 13
Rio de Janeiro 13
Stockholm 13
Hebei 12
Kunming 12
Phoenix 12
Tashkent 12
Andover 11
Atlanta 11
Manchester 11
Quito 11
Zhengzhou 11
Amsterdam 10
Boston 10
Edmonton 9
Grafing 9
Jiaxing 9
Jinan 9
Montréal 9
Turku 9
Brno 8
Copenhagen 8
Da Nang 8
Jeddah 8
Lahore 8
Nuremberg 8
Salt Lake City 8
Belo Horizonte 7
Cape Town 7
Caracas 7
Columbus 7
Haiphong 7
Totale 8.339
Nome #
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide 715
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro 472
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes 462
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 455
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide 440
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 424
Morphogenic effect of common solvent in the self-assembly behavior of amphiphilic PEO-b-PLA 412
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model 408
Fluorimetric detection of the earliest events in amyloid β oligomerization and its inhibition by pharmacologically active liposomes 398
The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease 373
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 363
Curcumin derivatives as new ligands of Aβ peptides 343
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages 331
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 331
Functionalized liposomes and phytosomes loading Annona muricata L. aqueous extract: Potential nanoshuttles for brain-delivery of phenolic compounds 326
Combinatorial Approaches to Iminosugars as Glycosidase and Glycosyltransferase Inhibitors 315
Abeta peptide toxicity is reduced after treatments decreasing phosphatidylethanolamine content in differentiated neuroblastoma cells 302
Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: The chemical design affects the permeability across an in vitro model 301
Synthesis and biological evaluation of a small library of nojirimycin derived bicyclic iminosugars 298
Fructose-based proline analogues: Exploring the prolyl trans/cis-amide rotamer population in model peptides 283
mApoE-Functionalized Nanoliposomes Delivering Doxorubicin and Ultrasmall Superparamagnetic Iron Oxide to Glioblastoma Cells Characterized by TEM and Confocal Microscopy 273
Synthesis and characterization of a paramagnetic sialic acid conjugate as probe for magnetic resonance applications 272
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease? 267
A membrane-bound trehalase from Chironomus riparius larvae: Purification and sensitivity to inhibition 261
Functionalization with curcumin-derivative and TAT peptide enhances the interaction with human brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 257
THE TOXIC EFFECT OF ABETA OLIGOMERS MAY BE REDUCED BY LIPID-BASED NANOPARTICLES IN HUMAN EX-VIVO MODELS 256
A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1 Delta E9 Mouse Model of Alzheimer's Disease 255
Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide 253
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice 253
Lipid-based nanoparticles as a potential tool to reduce abeta toxic effect in a human cellular model 251
Nanomedicine for the treatment of Alzheimer's disease 250
Lipid-based nanoparticles with high binding affinity for amyloid-b1e42 peptide 248
Nanotechnology for neurodegenerative disorders 240
Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune response 236
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease 236
Stability of Aβ (1-42) peptide fibrils as consequence of environmental modifications 232
Binding of lipid-based nanoparticles to plasma abeta: relevance for new therapeutic strategies in Alzheimer’s disease 230
Glycans in Magnetic Resonance Imaging: Determinants of Relaxivity to Smart Agents, and Potential Applications in Biomedicine 223
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 222
Nanotechnology for neurodegenerative disorders 209
Liposomes functionalized with GT1b ganglioside with high affinity for amyloid beta-peptide 200
Design of nanoparticles for the treatment of brain tumors 185
Totale 13.061
Categoria #
all - tutte 36.912
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.912


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021152 0 0 0 0 0 0 0 0 0 0 51 101
2021/2022689 50 84 66 65 22 41 65 49 26 59 62 100
2022/20231.250 133 352 141 134 70 184 18 76 84 10 29 19
2023/2024803 17 35 49 51 108 197 166 38 50 10 10 72
2024/20251.659 94 186 123 62 138 62 106 57 169 261 146 255
2025/20263.773 487 193 354 430 544 216 624 173 312 396 44 0
Totale 13.061